Self-management in patients with bronchial asthma Respiratory
Conditions
Interventions
This randomised controlled trial compares the use of a pictorial asthma action plan (PAAP) vs a text-based asthma action plan (tAAP) among adult patients with asthma in public primary care clinics in
Sponsors
University of Edinburgh
Eligibility
Sex/Gender
All
Age
18 Years to 110 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or older under follow up care. 2. Asthma diagnosed by a health care practitioner. 3. Prescribed with daily inhaled corticosteroids (ICS) for poor asthma control in the last year (according to Global Initiative for Asthma (GINA) Asthma Symptoms Control (2022) step 2 management for asthma control), in addition to as needed inhaled short-acting beta2-agonist (SABA); or as needed low dose ICS-formoterol for those on SMART therapy (Global Initiative for Asthma, 2022) 4. Willing and able to provide written informed consent. 5. Able to understand Malay (national language of Malaysia) or English. Detailed participant inclusion criteria for health care providers: 1. Health care providers who are involved in the management of asthma in the clinics 2. Willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: Detailed participant exclusion criteria for patients: 1. Less than 18 years of age 2. Unwilling or unable to provide written informed consent. 3. Co-morbid conditions prohibiting participation such as diagnosed cognitive impairment. 4. Diagnosed with other chronic respiratory disease (e.g. chronic obstructive pulmonary disease). 5. People whose family member living in the same household is a participant of this study. Detailed participant exclusion criteria for health care providers: 1.Health care providers who are on long leave (more than 1 month) during the period of data collection, for example, those on subspecialty attachment leave or maternity leave. 2. Unwilling to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma control measured using the validated Global Initiative for Asthma (GINA) Asthma Symptoms Control at 3, 6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessed at 3, 6 and 12 months: 1. Number of times reliever medication (inhaled or oral bronchodilators) is used in the past month 2. Adherence to controller medication in the past month 3. Frequency of acute exacerbations (defined as episodes characterised by acute or subacute onset of progressively worsening symptoms, such as shortness of breath, cough, wheezing or chest tightness, which are worse than the patient's usual status and require a change in treatment) in the past month 4. Frequency of asthma-related emergency visits (to a health clinic and/or hospital emergency department) in the past month 5. Frequency of asthma-related admissions in the past month 6. Number of days lost from work for asthma treatment (defined as the number of days of medical leave taken by an employee, or unable to work if self-employed) in the past month 7. Number of times the participants reported using their pictorial asthma action plan in the previous month | — |
Countries
Malaysia
Outcome results
None listed